Skip to main content
Premium Trial:

Request an Annual Quote

Pepscan Enters Protease Collaboration with Solvay

NEW YORK, March 8 (GenomeWeb News) - Pepscan Systems and its Benelux distributor ServiceXS have entered into an agreement with Solvay Pharmaceuticals to de-orphanize a series of proteases, the companies said today.

 

Under the terms of the agreement, Pepscan and ServiceXS will use "rationally and randomly designed" peptide arrays to identify novel peptide substrates for a series of proteases proprietary to Solvay, the companies said.

 

Financial terms of the deal were not disclosed.

 

ServiceXS, based in Leiden, The Netherlands, has been the official distributor for Lelystad-based Pepscan Systems in the Benelux region since 2003.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.